Page last updated: 2024-08-26

lysophosphatidic acid and Neointima

lysophosphatidic acid has been researched along with Neointima in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bhattarai, S; Manikandan, S; Miriyala, S; Panchatcharam, M; Sharma, P; Sharma, S; Subedi, U; Sun, H1
Guo, T; Li, F; Shen, X; Zhang, T; Zou, J1
Chevalier, E; Dembowsky, K; Hamesch, K; Li, X; Schober, A; Subramanian, P; Weber, C1
Amour, J; Atassi, F; Gaaya, A; Hery, T; Lompré, AM; Marchand, A; Mougenot, N; Nadaud, S; Poirier, O; Saulnier-Blache, JS; Soubrier, F; Vogt, J1
Dong, A; Escalante-Alcalde, D; Miriyala, S; Morris, AJ; Mueller, P; Panchatcharam, M; Salous, A; Smyth, SS; Sunkara, M; Wheeler, J1

Other Studies

5 other study(ies) available for lysophosphatidic acid and Neointima

ArticleYear
The Autotaxin-LPA Axis Emerges as a Novel Regulator of Smooth Muscle Cell Phenotypic Modulation during Intimal Hyperplasia.
    International journal of molecular sciences, 2023, Feb-02, Volume: 24, Issue:3

    Topics: Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Hyperplasia; Mice; Myocytes, Smooth Muscle; Neointima; Phenotype

2023
Lysophosphatidic acid enhances neointimal hyperplasia following vascular injury through modulating proliferation, autophagy, inflammation and oxidative stress.
    Molecular medicine reports, 2018, Volume: 18, Issue:1

    Topics: Animals; Atherosclerosis; Cell Proliferation; Hyperplasia; Inflammation; Lysophospholipids; Male; Neointima; Oxidative Stress; Rats; Rats, Sprague-Dawley

2018
The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without impairing re-endothelialisation.
    Thrombosis and haemostasis, 2012, Volume: 107, Issue:2

    Topics: Angioplasty; Animals; Apolipoproteins E; Blood Vessel Prosthesis Implantation; Carotid Arteries; Cell Movement; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Humans; Lysophospholipids; Macrophages; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Neointima; Postoperative Complications; Proteins; Receptors, CXCR4; Sirolimus

2012
Plasticity-related gene-1 inhibits lysophosphatidic acid-induced vascular smooth muscle cell migration and proliferation and prevents neointima formation.
    American journal of physiology. Cell physiology, 2012, Nov-15, Volume: 303, Issue:10

    Topics: Adenoviridae; Animals; Calmodulin-Binding Proteins; Cell Movement; Cell Proliferation; Cells, Cultured; Gene Expression Regulation; Genetic Vectors; Humans; Lysophospholipids; Male; Muscle, Smooth, Vascular; Neointima; Phosphoric Monoester Hydrolases; Rats; Rats, Wistar

2012
Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia.
    Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:1

    Topics: Animals; Carotid Artery Injuries; Carotid Artery, Common; Cell Movement; Cell Proliferation; Disease Models, Animal; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Genotype; HEK293 Cells; Humans; Hydrolysis; Hyperplasia; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Phenotype; Phosphatidate Phosphatase; rho-Associated Kinases; Signal Transduction; Time Factors; Transfection

2013